Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F. Ambinder

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
Blood Advances|December 18, 2024
Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphomaNadeem Tabbara, Marianna Zahurak, Cole H Sterling, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanningYvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
International Journal of Cancer|July 23, 2008
Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populationsSally L Glaser, Margaret L Gulley, Christina A Clarke, et al.
The Journal of Infectious Diseases|October 13, 2011
Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarrayDasheng Zheng, Jun Wan, Yong Gu Cho, et al.
Frontiers in Oncology|December 31, 2021
Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt LymphomaRena R Xian, Tobias Kinyera, Isaac Otim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2003
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cellsCarol Ann Huff, Ephraim J Fuchs, Stephen J Noga, et al.
Cell Host & Microbe|October 25, 2011
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replicationRenfeng Li, Jian Zhu, Zhi Xie, et al.
Blood Advances|April 21, 2020
CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphomaMeir Shamay, Jennifer A Kanakry, John S W Low, et al.
The Journal of Infectious Diseases|January 26, 2012
HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapyChristine M Durand, Gabriel Ghiaur, Janet D Siliciano, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
Blood Advances|December 18, 2024
Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphomaNadeem Tabbara, Marianna Zahurak, Cole H Sterling, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanningYvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
International Journal of Cancer|July 23, 2008
Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populationsSally L Glaser, Margaret L Gulley, Christina A Clarke, et al.
The Journal of Infectious Diseases|October 13, 2011
Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarrayDasheng Zheng, Jun Wan, Yong Gu Cho, et al.
Frontiers in Oncology|December 31, 2021
Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt LymphomaRena R Xian, Tobias Kinyera, Isaac Otim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2003
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cellsCarol Ann Huff, Ephraim J Fuchs, Stephen J Noga, et al.
Cell Host & Microbe|October 25, 2011
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replicationRenfeng Li, Jian Zhu, Zhi Xie, et al.
Blood Advances|April 21, 2020
CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphomaMeir Shamay, Jennifer A Kanakry, John S W Low, et al.
The Journal of Infectious Diseases|January 26, 2012
HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapyChristine M Durand, Gabriel Ghiaur, Janet D Siliciano, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Pageof 22